aTyr Pharma, Inc. (ATYR) NASDAQ

0.87

-0.0508(-5.51%)

Updated at March 12 01:21PM

Currency In USD

Valuation

Market Cap72.82M
Enterprise Value74.11M
P/E Ratio-1.15
PEG Ratio-0.24
Price/Sales Ratio449.19
Price/Book Ratio1.27
Enterprise/Revenue455.98
Enterprise/EBITDA-1.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-390.09
Operating Margin-408.56

Management Effectiveness

Return On Assets-0.79
Return On Equity-1

Income Statement

Revenue190,000
Revenue/Share0
Gross Profit-1.36M
EBITDA-76.07M
Net Income-74.12M
Diluted EPS-0.8

Balance Sheet

Total Cash78.69M
Total Cash/Share0.8
Total Debt12.03M
Total Debt/Equity0.18
Current Ratio5.3
Book Value Per Share0.69

Price History

52-Week Change-75.46
52-Week High7.29
52-Week Low0.64
Moving Average 50 Days0.85
Moving Average 200 Days2.54

Statistics

Average Volume2.01M
Shares Outstanding97.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:14
Last Split DateJuly 01, 2019